1. Home
  2. ASTE vs CVAC Comparison

ASTE vs CVAC Comparison

Compare ASTE & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astec Industries Inc.

ASTE

Astec Industries Inc.

HOLD

Current Price

$46.44

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo CureVac N.V.

CVAC

CureVac N.V.

HOLD

Current Price

$5.08

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTE
CVAC
Founded
1972
2000
Country
United States
Germany
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ASTE
CVAC
Price
$46.44
$5.08
Analyst Decision
Hold
Hold
Analyst Count
1
3
Target Price
$41.00
$6.83
AVG Volume (30 Days)
176.9K
1.7M
Earning Date
11-05-2025
11-24-2025
Dividend Yield
1.12%
N/A
EPS Growth
N/A
94.02
EPS
2.08
0.94
Revenue
$1,368,800,000.00
$83,000,117.00
Revenue This Year
$8.19
N/A
Revenue Next Year
$6.23
$23.40
P/E Ratio
$22.41
$5.39
Revenue Growth
6.66
N/A
52 Week Low
$29.65
$2.48
52 Week High
$50.83
$5.72

Technical Indicators

Market Signals
Indicator
ASTE
CVAC
Relative Strength Index (RSI) 57.44 41.06
Support Level $43.77 $5.05
Resistance Level $47.56 $5.20
Average True Range (ATR) 1.57 0.14
MACD 0.45 -0.01
Stochastic Oscillator 84.59 20.83

Price Performance

Historical Comparison
ASTE
CVAC

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

Share on Social Networks: